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Abstract
Background: The prevalence of non-communicable diseases, and associated morbidity and mortality, is increasing
rapidly in low and middle-income countries where health systems often have limited access and lower quality of
care. The intervention was to decentralise uncomplicated non-communicable disease (NCD) care from a hospital to
nurse practitioners in health centres in a poor rural district in Eswatini, southern Africa. The objective of this study
was to assess the feasibility and impact of decentralised care for NCDs within nurse-led clinics in order improve
access and inform healthcare planning in Eswatini and similar settings.
Methods: In collaboration with the Eswatini Ministry of Health, we developed and implemented a package of
interventions to support nurse-led delivery of care, including: clinical desk-guide for hypertension and diabetes,
training modules, treatment cards and registries and patient leaflets. Ten community clinics in the Lubombo Region
of Eswatini were randomly selected to be trained to deliver NCD care for a period of 18 months. Observational data
on follow-up rates, blood pressure (BP), glucose etc. were recorded and evaluated. We compared blood pressure
and blood glucose measurements between the first and fourth visits and fitted a linear mixed effects model.
Results: One thousand one hundred twenty-five patients were recruited to the study. Of these patients, 573
attended for at least 4 appointments. There was a significant reduction in mean BP among hypertensive
patients after four visits of 9.9 mmHg systolic and 4.7 mmHg diastolic (p = 0.01), and a non-significant reduction
in fasting blood glucose among diabetic patients of 1.2 mmol/l (p = 0.2). Key components of NCD care were
completed consistently by nurses throughout the intervention period, including a trend towards patients
progressing from monotherapy to dual therapy in accordance with prescribing guidelines.
Conclusions: The findings suggest that management of diabetes and hypertension care in a rural district setting
can be safely delivered by nurses in community clinics according to a shared care protocol. Improved access is
likely to lead to improved patient compliance with treatment.
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Background
Non-Communicable Diseases (NCDs) are responsible
for 40.5 million deaths globally each year, equivalent to
71% of all deaths [1]. Rates of new NCD diagnoses are
rising fastest in low and middle income countries, with
these countries experiencing 85% of all ‘premature’
deaths due to NCDs (between the age of 30 and 69) [2].
NCD care is among the tracer interventions used to
measure coverage of essential health services under Sus-
tainable Development Goal Target 3.8 ‘Achieve universal
health coverage’ [3].
Eswatini (formerly Swaziland) is a country with a
population of 1.1 million people in Southern Africa [4].
Similar to many neighbouring countries it was severely
affected by HIV/AIDS. Well-coordinated HIV pro-
grammes have led to significant reductions in HIV inci-
dence and mortality. At the same time, prevalence of
NCDs and lifestyle risk factors have been increasing:
The most recent WHO STEPS survey reported rates of
obesity to be 31% in women and 8.8% in men [5]. High
fasting blood glucose (> 7.0 mmol/l) was found in 17% of
women and 11% of men and 22% of adults have hyper-
tension [5, 6]. NCDs are estimated to now be respon-
sible for 37% of all deaths in the country [6].
Traditionally, NCD care in Eswatini has been provided
using a centralised model, with the majority of care pro-
vided by hospitals. Patients have limited access and com-
monly present late with symptoms of complications.
Hospital services are working at full capacity, with little
room for expansion. With increasing burden on hospital
resources caused by HIV and now the ‘double burden’ of
NCDs, this model of care is no longer sustainable.
Neighbouring South Africa has worked to control NCDs
through health systems strengthening [7], moving to-
wards Integrated Chronic Disease Management’ [8],
emphasising ‘assisted self-care’ where patients are
assisted to become more expert and adjust their diet, in-
sulin or drugs within a limited range agreed with their
clinician. This is a long-term relationship of on-going
education and support provided by (preferably the same)
health worker. In 2013, the Eswatini Ministry of Health’s
National NCD programme began developing a national
NCD strategy to address morbidity and premature mor-
tality caused by NCDs [9]. One component of the strat-
egy has been the development and implementation of a
comprehensive integrated NCD service in health centres
(called ‘community clinics’ in southern Africa).
The study was conducted within the Lubombo region
of Eswatini, a recently drought-stricken area with a high
rate of extreme poverty. Lubombo is a predominantly
rural region with a population of 212,500 and one of the
highest prevalence rates of HIV in the world with 29% of
those aged 15 and over infected with HIV [10]. The re-
gion has one district general hospital, two health centres
and a network of 40 nurse-run primary care community
clinics. Good Shepherd Hospital (GSH) is a former mis-
sion ‘regional’ (rural district) hospital with primary re-
sponsibility for tertiary care in the Lubombo region, and
so was the focal point for the study. At GSH in 2011,
1588 outpatient appointments were due to diabetes
(DM), 3015 due to hypertension (HT), and 1444 due to
cardiovascular disease (CVD); the numbers of patients
treated are not known (unpublished data).
Currently GSH has one clinic specifically for diabetes/
hypertension, run by a team of nurses and assistants.
The community clinics provide hypertensive and dia-
betic services on an ad hoc basis. Some community
clinics provide a refill service for these medications,
though supplies are inconsistent and access for patients
to NCD medication is unreliable. A few community
clinics have a doctor visit once a month to attend to pa-
tients for diagnoses and complications. Prior to the
study, community clinic staff had not received specific
training/ guidance on the management of NCDs. GSH is
currently responsible for supervision and support of 18
clinics in Lubombo. This pilot project and prospective
cohort study was designed to decentralise NCD care
from a regional hospital to nurse-led community clinics
in the rural Lubombo region. The objective of this study
is to assess the feasibility and impact of decentralised
care for NCDs within nurse-led clinics in the Lubombo
region, Eswatini, in order improve access and inform
healthcare planning in Eswatini and similar settings.
Methods
This observational study began with preparatory work to
ensure the clinics were equipped with necessary equip-
ment including a weight scale, BP machine and gluc-
ometer to diagnose and treat type II diabetes and
hypertension, along with patient information leaflets.
We developed a treatment guideline in the form of a
desk guide for cardiovascular disease, diabetes and
hypertension, which dealt with: primary prevention,
identification and screening, diagnosis, education, treat-
ment and referral. The desk guide describes different
thresholds for blood pressure control for patients with
only hypertension (140/90mmHg) compared to patients
who also have diabetes (130/80 mmHg). The desk guide
states a target fasting blood glucose of 7 mmol/l for ef-
fective glycaemic control. We developed and adminis-
tered a 3.5-day skill-based and interactive, training
programme for clinic nurses, which covered all elements
of the desk guide including data collection, and was
based around a combination of lectures, demonstrations
and interactive case study based clinical role-plays. The
Chief Pharmacist and national pharmaceutical dispens-
ary made provisions to allow distribution of anti-
hypertensive and anti-diabetic medications by trained
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nurse-practitioners. Clinics were provided with the fol-
lowing data collection tools: patient-held heath record
card, client-held health record card, enrolment register,
and annual review card.
The patients enrolled in the study were recruited from
community clinics based on their health status; being di-
agnosed with Type II diabetes mellitus (DM), hyperten-
sion (HTN), or cardiovascular disease (CVD) in
accordance with the International Classification of Dis-
eases criteria. Patients with Type I or Type II diabetes
requiring insulin were excluded from the study.
The following information was collected at baseline
and during each follow up visit as appropriate: demo-
graphics (age, date of birth, sex, occupation, and educa-
tion level), weight, waist circumference, blood pressure
(BP) readings, random/fasting blood glucose readings
(RBG and FBG respectively), HIV and TB status, medi-
cines prescribed, and any other conditions the patient
may have.
We described the baseline characteristics and the
trend in health indicators over time, specifically: mean
and standard deviation (sd) of systolic and diastolic
blood pressure, the proportion of blood pressure read-
ings above diagnostic and safety thresholds, and fasting
blood glucose, and completion of routine clinical tasks.
We compared blood pressure and blood glucose mea-
surements between the first and fourth visits and fitted a
linear mixed effects model with the difference in magni-
tude between the first and fourth visit as the outcome
(dependent) variable and a random intercept for the
clinic, to assess whether any change was significant,
while accounting for the clustered nature of the data.
We used the Kenward-Roger approximation to get ap-
proximate degrees of freedom for the t-distribution to
get p-values and calculated confidence intervals via the
profile likelihood method.
Ethics approval and consent to participate
Verbal consent for inclusion in the study was obtained
from participants on enrolment. As an operational re-
search study, the project was focused on the service out-
comes and it was not proposed that written consent be
requested from individual patients to secure their par-
ticipation. This study was approved by the Leeds Univer-
sity Faculty of Medicine and Health Research Ethics
Committee and the Eswatini National Health Research
Review Board.
Results
A defined six-month period for enrolment allowed for
recruitment of sufficient numbers and the establishment
of decentralisation at intervention clinics. Data collection
was complete 12 months after enrolment. The total
study duration was therefore 18 months (6 months
recruitment + 12months’ follow-up). One thousand one
hundred twenty-five patients were recruited to the inter-
vention clinics in total 923 (82%) had hypertension
alone, 68 (6%) had diabetes alone and 134 (12%) had
both diabetes and hypertension (Table 1). 78% of those
recruited to the intervention were women. The mean
age for women patients was 61 years and 63 years for
men. The average weight of recruited patients with
hypertension was 77 kg, compared to patients with dia-
betes who on average weighed 82 kg. Average waist cir-
cumference was 99 cm for hypertensive patients and
102 cm for diabetic patients. Numbers recruited per
clinic ranged from 52 to 304. Data were collected for
4437 individual clinic appointments. Problems with data
collection and patient losses reduced the number of re-
corded follow-up appointments, but data was recorded
for 573 patients who attended at least 4 appointments.
Table 1 Recruited participants by age, sex and diagnosis
N %
Age group
20–30 6 1
30–40 48 4
40–50 143 13
50–60 245 22
60–70 292 26
70–80 189 17
80–90 40 4
90–100 7 1
Unknown 155 14
Gender
Female 875 78
Male 247 22
Unknown 3 0
Education
None 419 37
Primary 333 30
Secondary 127 11
Unknown 246 22
Diagnosis
Hypertension 923 82
Diabetes 68 6
Hypertension & Diabetes 134 12
New patients
New 49 4
Existing 847 75
Unknown 229 20
Total 1125 100
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Data on all other variables is taken from the fixed co-
hort of 573 patients who attended at least 4 follow-up
visits, to allow meaningful comparisons to be made. This
group consisted of 43 who had diabetes alone, 79 with
diabetes and hypertension and 451 with hypertension
alone. We analysed blood pressure separately for pa-
tients with and without diabetes due to different target
blood pressure, while we analysed fasting blood glucose
for all diabetic patients together. Only 18 of these pa-
tients were diagnosed during the study period so they
are considered together with existing patients.
Blood pressure control
BP control - hypertension only
Table 2 summarises the trends in blood pressure for pa-
tients in this cohort with hypertension only (n = 451)
seen over four visits.
The mean systolic BP for this cohort on enrollment
was 149 mmHg (range 90–259 mmHg). By Visit 4 this
had fallen to 139 mmHg (range 88–240 mmHg). Mean
diastolic BP was 88mmHg (range 41–134 mmHg) on
enrolment and fell to 81 mmHg (range 50–123 mmHg)
by Visit 4. The change in both systolic and diastolic
blood pressure in this group was statistically significant
(p = 0.01) (Table 4). Using the target of 140/90 mmHg,
57% of this cohort had poor systolic blood pressure
(SBP) control at baseline and 29.3% had poor diastolic
blood pressure (DBP) control. These figures fell to 39
and 18% respectively by Visit 4. The variation in valid
values may be due to BP not being taken or not being
recorded.
A blood pressure reading of above 180/100mmHg is
listed as a safety threshold in the Desk Guide, above
which level patients require urgent review. At baseline,
13% of these patients had SBP values above this level
and 4.0% had DBP values above this level. These propor-
tions fell to 7.1 and 1.4% respectively over the course of
the intervention.
BP control - diabetes and hypertension
The treatment target for diabetic patients with hyperten-
sion is 130/80 mmHg. Table 3 summarises blood pres-
sure control for the cohort of patients who were
managed for both diabetes and hypertension (n = 79)
and seen for at least four scheduled visits.
Average SBP readings were similar to those seen in
the hypertension cohort; ranging from systolic 148
mmHg at Visit 1 (100–218 mmHg) to 139 mmHg at
Visit 4 (108–194 mmHg) and diastolic 86 mmHg at visit
1 (41–131mmHg) to 81mmHg at visit 4 (59–109).
Table 4 shows the results of a linear mixed effects model
of the change in BP and blood sugar accounting for clus-
tering by clinic. Note the number of observations refers
only to those observations where both the first and
fourth visit values were complete. The change in both
systolic and diastolic blood pressure in this group was
statistically significant (p = 0.04). At baseline, the propor-
tion of diabetic patients failing to reach the target
threshold for SBP (130mmHg) was 75%, falling to 58%
by Visit 4. The proportion having poor DBP control also
improved from 63 to 47%. Only small numbers of dia-
betic patients exceeded the safety threshold (180/110
mmHg). The overall proportion with SBP greater than
180 fell from 10 to 3.9% between Visit 1 to 4.
Blood glucose control
Fasting blood glucose (FBG) was the diabetic param-
eter most frequently recorded in this intervention.
Table 5 shows the trend in FBG for patients with dia-
betes (n = 122 who attended four visits or more. The
mean fasting blood glucose for this cohort on enroll-
ment was 9.6 mmol/l (range 4.2–22 mmol/l). By Visit
4 this had fallen slightly to 8.9 mmol/l (range 4.4–
25.3 mmol/l). This change was not statistically signifi-
cant (p = 0.2). There were fewer observations for
fasting blood glucose which was not assessed as regu-
larly as blood pressure.
Table 2 Trend in Blood Pressure: Hypertension only (n = 451)
Parameter Value Visit 1 Visit 2 Visit 3 Visit 4
Systolic BP (mmHg) Valid values 429 434 419 422
Mean (sd.) 149 (28) 142 (24) 138 (22) 139 (24)
Range 90–259 95–222 90–210 86–240
Values > 140 (%) 57 46 39 39
Values > 180 (%) 13 7 5 7
Diastolic BP (mmHg) Valid values 427 432 413 419
Mean (sd.) 86 (14) 81 (13) 81 (13) 81 (13)
Range 49–134 48–141 50–124 50–123
Values > 90 (%) 29 20 19 18
Values > 110 (%) 4 2 1 1
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Fasting blood glucose readings over 10 mmol/l indicate
poor control. The proportion of these readings reduced
from 40% at baseline to 31% after four visits.
Medication usage
Studying the defined cohort of 573 patients who
attended four or more visits allows patterns in the usage
of medication for diabetes and hypertension to be ana-
lysed. The Desk Guide states that patients should be
started on Metformin and have a Sulfonylurea (typically
Glibenclamide) added if control is poor (or if Metformin
cannot be tolerated). At baseline, 17 patients (17%) of
diabetic patients on medication were on Metformin only,
compared to 8.1% on Glibenclamide only and 79% tak-
ing both Metformin and Glibenclamide. The numbers
on dual therapy increased slightly over the course of the
intervention. By visit 4, 83 diabetic patients (82%) were
on both Metformin and Glibenclamide.
Process indicators
Data was also captured on process indicators describing
how closely the delivery of the intervention met the
standards outlined in the Desk Guide. The Desk Guide
advised that patients should attend community clinics
for monthly reviews. For each NCD visit nurses were ex-
pected to provide health education and to complete
tasks including weight and BP checks (all patients) and
blood glucose (diabetic patients).
The completion of routine tasks required by the inter-
vention is illustrated in Table 6 (based on the cohort at-
tending at least 4 appointments). Weight and BP were
checked for almost all patients throughout the interven-
tion. Blood glucose was measured less reliably, and the
proportion fell during the intervention from 75% of dia-
betic patients at Visit 1 to 68% of patients at Visit 4. At
least three-quarters of patients were documented to have
received some form of health education at every visit, al-
though this proportion appeared to fall over the inter-
vention. Health education included: diet, sugar, salt,
medication adherence, exercise, smoking and stress
management.
Table 7 shows that over the course of the intervention
the average intervals (in days) between appointments
remained relatively stable at just over the recommended
monthly interval. There was no clear evidence of a drop-
off in appointment intervals as the intervention pro-
gressed (based on data for all patients).
Discussion
A large cohort of patients were found to have improving
trends on average with treatment in all physiological pa-
rameters (including extreme values) over four visits. A
statistically significant reduction in blood pressure was
observed between the first and fourth visits among
hypertensive patients with and without diabetes, how-
ever no significant change in blood glucose was observed
and a significant proportion of patients remained above
targets at follow-up. BP was checked in nearly all pa-
tients at all visits. Glucose was checked at more than 2/
3rds of diabetic patient visits (though a lower percentage
in visit 3 for unknown reasons). Health education was
given to the large majority of patients, especially at the
first visit when care was initiated. Medication usage
demonstrates that patients’ drug/doses and were
‘stepped-up’ during the period, as recommended by the
Desk Guide, with a trend towards the combination re-
gimes. The process indicators demonstrate the ability of
nurses in community clinics to successfully deliver the
components of NCD care.
This study adds to the evidence base of similar health
system interventions in low and middle-income coun-
tries. Recent experience in Pakistan developing case
management packages played an important role in
Table 3 Trend in Blood Pressure: Hypertension AND diabetes
(n = 79)
Parameter Value Visit 1 Visit 2 Visit 3 Visit 4
Systolic BP Valid values 77 74 76 77
Mean (sd.) 148 (24) 144 (21) 138 (22) 139 (19)
Range (mmHg) 100–218 100–210 94–188 108–194
Values > 130 (%) 75 72 59 58
Values > 180 (%) 10 7 5 4
Diastolic BP Valid values 75 74 76 77
Mean (sd.) 86 (15) 82 (12) 83 (12) 81 (10)
Range 41–131 52–107 48–120 59–102
Values > 80 (%) 63 51 49 47
Values > 110 (%) 3 0 3 0
Table 4 Linear mixed effects models of change in blood pressure and fasting blood glucose between first and fourth visits
Clinical group Parameter Difference Lower 95% CI Upper 95% CI P value* N Observations N groups
Hypertension only Systolic BP −9.9 −13.2 −6.0 0.01 405 10
Diastolic BP −4.7 −7.1 −2.3 0.01 402 9
Hypertension and diabetes Systolic BP −8.2 −14.1 − 1.8 0.04 75 7
Diastolic BP −5.4 −9.4 −1.7 0.04 73 7
Fasting blood glucose diabetic patients Fasting blood glucose −1.2 −2.7 0.3 0.2 37 7
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helping to prioritise diabetes, hypertension, CVD,
asthma and chronic obstructive pulmonary disease pre-
vention across Punjab Province, leading to better provin-
cial planning and budgeting and demonstrating that
primary and secondary public health facilities can effect-
ively deliver integrated NCD care in a developing coun-
try context [11–13]. Those research-informed guides
and tools have been scaled up for use across the 150
public hospitals in Punjab Province. In China, it was
shown that by implementing a cardiovascular disease
(CVD) care package by family doctors in rural township
hospitals can improve prescribing practice and encour-
age modest improvements in lifestyle changes such as
quitting smoking and reduced salt and alcohol intake
[14, 15]. Additional measures such as innovative patient
education and improved health insurance coverage for
outpatients could have helped the CVD care package to
be even more effective. The CVD/diabetes care package
was adopted and scaled up in the control hospitals.
These studies along with our example show that imple-
menting an enhanced package of care in an integrated
fashion is both feasible and scalable in low and middle-
income settings. In Eswatini the package has been
adopted nationally, with plans and funding to scale up
across the country.
There were several operational challenges that arose
and lessons can be learned from these for future service
developments. Despite the agreement to allow clinics to
order drugs, there were still problems with organising
distribution to the community clinics, which incurred
long periods of stock outs. There were often issues with
transportation, specifically availability of vehicles and ac-
cessibility as many community clinics are not located on
roads that are well-paved, with greater difficulty after
heavy rainfall. Community clinic nurses have many other
duties, such as child health, limiting their attention to
diabetes and hypertension care. Specialist nurse supervi-
sion from the hospital helped to maintain enthusiasm
for the intervention among the stakeholders, but it was
challenging to sustain these visits at the necessary fre-
quency. Patients with abnormal parameters or poor re-
sponse to treatment were required by the protocol to be
reviewed by a hospital doctor. This was an access a bar-
rier which resulted in some patients remaining on sub-
optimal treatment. This barrier could be overcome if, as
for HIV and TB services in Eswatini, doctors visit and
see complex cases at the community clinics.
Limitations
The observational nature of the data means that no firm
conclusion can be drawn as to whether care under the
new model is better or worse than current practice. The
change in blood pressure between the first and fourth
visits was statistically significant, but regression to the
mean cannot be ruled out. There were significant losses
to follow up, which may have been due to patients de-
clining further treatment or seeking treatment elsewhere
or may have also been an apparent loss due to poor rec-
ord keeping. There is a risk of bias due to differential
loss to follow up, where the least healthy or compliant
patients drop out or keep poorer records, meaning the
final sample may not be representative of the general
population. There was consistent rotation of nursing
staff on the local level presenting challenges. The geo-
graphical remoteness of the clinics meant central moni-
toring of these processes was challenging. The style of
recording patient information in Eswatini involves med-
ical staff writing signs, symptoms, vital statistics, diagno-
ses, and prescriptions in a patient-held notebook, which
the patient keeps together with any other clinical docu-
ments. These patient-held records may have been well
utilised, along with the patient-held cards used in the
Table 5 Trend in fasting blood glucose control (n = 122)
Parameter Value Visit 1 Visit 2 Visit 3 Visit 4
Fasting blood glucose (mmol/l) Valid values 81 75 70 75
Mean (sd.) 9.6 (4.3) 8.8 (3.8) 9.4 (3.9) 8.9 (4.0)
Range 4.2–22 3.8–23 3.9–23 4.4–25
Values > 7 (%) 62 56 64 60
Values > 10 (%) 40 31 34 31
Table 6 Completion of routine clinical tasks over time
Task Hypertension Diabetes
Visit 1 Visit 2 Visit 3 Visit 4 Visit 1 Visit 2 Visit 3 Visit 4
BP checked 96% 96% 93% 94% 97% 95% 96% 94%
Blood glucose checked N/A N/A N/A N/A 75% 70% 63% 68%
Weight taken 83% 95% 93% 93% 73% 90% 89% 89%
Health education given 90% 80% 78% 77% 98% 77% 77% 75%
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study, however, because these were kept by the patient,
it was not possible to include their data. Given the limi-
tations of this study design, further studies would be ne-
cessary to provide stronger evidence of benefit, perhaps
including a ‘routine care’ control group. That said, the
model proved to be feasible and accessibility of care was
improved, and these results add to the evidence base
supporting the decentralisation of NCDs in similar
settings.
Conclusion
These findings suggest that decentralization of care for
NCDs in low resource settings is feasible and associated
with improvements in physiological parameters, though
continued training and supervision are required to
embed change. Nurses in participating community
clinics in Lubombo are now better equipped to recog-
nise and correctly diagnose hypertension and diabetes,
and they can initiate treatment and follow up uncompli-
cated patients. They are also able to follow up and moni-
tor more complex cases and provide refills of drugs
normally only available in hospital. Finally, they are
using a record keeping system that will help with follow-
up care and identify loss to follow-up or treatment fail-
ure, though the quality of recording has deteriorated,
and further support and supervision is needed to im-
prove this.
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